© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
Tranylcypromine sulfate carries a legacy that stretches back to the early days of psychiatric drug development. Synthesized for the first time in the late 1950s, this compound didn’t burst onto the scene by intent—its roots trace back to research on amphetamine and related chemicals, hunting for new antidepressants after clinicians spotted unexpected mood changes in patients taking early monoamine oxidase inhibitors. The pharmaceutical landscape at the time brimmed with trial and error, stories traded in hospital corridors about unpredictable effectiveness and daunting side effects. Tranylcypromine emerged from this climate not by being a perfect fit, but for offering hope where little existed for patients stuck in the grip of deep, unyielding depression.
A look at a bottle of tranylcypromine sulfate may not reveal its complicated backstory, but every dosage form dropped onto a pharmacy counter speaks to decades of use. Known commercially under names like Parnate, this compound commonly appears in tablet format, typically colored for easy identification. As a monoamine oxidase inhibitor, this drug doesn’t play by the current trend of fine-tuned receptor targeting; instead, it acts broadly, blocking the enzyme that breaks down key brain chemicals like serotonin and norepinephrine. This approach changes brain chemistry on a larger scale, a method respected for its power but worthy of careful respect.
Tranylcypromine sulfate doesn’t stand out at first glance. It exists as a white to off-white crystalline powder. Its chemical stability keeps it from breaking down easily under normal conditions, but it will absorb moisture from the air and prefers a cool, dry shelter. Chemically, it’s classified as a non-hydrazine monoamine oxidase inhibitor, with a cyclopropylphenyl backbone that gives it both its unique activity and some of its stubborn metabolic quirks. It dissolves well in water, which favors manufacturing, but brings challenges for those working to extend shelf life.
The route to tranylcypromine sulfate in the lab doesn’t involve mysterious secrets—it’s a direct synthesis that starts from phenylpropanone, proceeds through cyclization, and then rounds out with sulfonation. This process benefits from decades of chemical refinement. Yet, the greater challenge comes in tweaking the molecule for better tolerability or reduced side effects, something researchers still ponder amid the sea of new antidepressants. Chemical modification efforts have occasionally produced analogs in small research labs, but few reach clinical validation.
In the world of pharmaceuticals, a single compound often goes by many names. Tranylcypromine sulfate’s official designator, trans-2-phenylcyclopropylamine sulfate, surfaces on technical papers. In pharmacies, the name Parnate gets more attention. While the synonym pile reflects chemical structure and regulatory heritage, patients and clinicians care more about recognizable names and trusted effects. Different regulatory regions stick to their own conventions, which sometimes stirs confusion, especially when global research conferences or journals pull from multiple naming systems.
Every person who’s dispensed, handled, or administered tranylcypromine sulfate knows safety isn’t optional. The compound interacts with foods rich in tyramine—aged cheeses or cured meats—leading to spikes in blood pressure that can prove deadly if ignored. Health professionals warn patients in plain language, highlighting forbidden foods and watching for signs of adverse reactions. Safe use means checking for drug-drug interactions, keeping an eye on symptoms like headaches or palpitations, and respecting dosing instructions. Pharmacists stress that the smallest slip, such as an unreported migraine medication, can set off a dangerous chain reaction. Hospital protocols sit on shelves for good reason: monoamine oxidase inhibitors call for clinical experience and constant vigilance.
Even in a marketplace flooded with newer antidepressants, tranylcypromine sulfate holds onto a devoted following among psychiatrists and their patients facing stubborn depression. People who have tried everything else sometimes find that relief finally arrives with tranylcypromine, often after years of cycling through selective serotonin reuptake inhibitors or newer atypical agents. Application stretches beyond unipolar depression—researchers and prescribers look at cases of treatment-resistant depression and certain anxiety disorders, chasing after benefits for people whose symptoms have outlasted other approaches. Its power is undeniable, but so are the risks, narrowing its use to those truly in need.
Tranylcypromine sulfate’s reputation for robust effects attracts researchers keen to find lighter, safer alternatives for the most severe mood disorders. Labs measure tiny blood samples to spot how it alters neurotransmitter metabolism, hunting for clues that might help shape future molecules. Some teams test fixed-dose combinations or extended-release formulations, hoping to tame side effects or stretch out symptom relief. Biomedical engineers debate how to detect and prevent hypertensive crises before patients sense any warning. Much of today’s research steers clear of simple copy-cat drugs, instead looking for compounds inspired by tranylcypromine that deliver similar antidepressant activity with fewer safety headaches.
Tranylcypromine sulfate has a track record that health professionals learn as much from as any modern warning label. Diaries and patient records show a real risk of hypertensive crisis, especially if mixed with prohibited foods or medications. Liver toxicity rarely shows up, though, which sets it apart from many early antidepressants. Still, overdose can cause tremors, confusion, convulsions, and deadly complications. Toxicology studies point to careful titration and meticulous patient selection as smarter paths to safety. Medical teams use this information to plan follow-up, training patients to notice subtle warning signs, while pushing for newer compounds with wider safety windows.
The legacy of tranylcypromine sulfate shouldn’t be overlooked as mental health care pushes for safer, more effective treatments. New drugs keep chasing better tolerability, faster relief, and longer durability, yet some patients don’t respond without the dramatic mechanism that tranylcypromine brings. Novel formulations—longer-acting, lower peak effects, patient-friendly delivery—could ease some historical burdens, though progress in psychiatry has always run at a frustrating, uneven pace. Improving support systems, extending digital monitoring to watch for side effects in real time, and developing patient education tools all offer ways to keep people safe while getting the benefits that older drugs can provide. The safest journey forward relies on old-fashioned caution, real-world experience, and never losing sight of the tough cases who count on alternatives that work when everything else fails.
Tranylcypromine sulfate stands out as a medication often prescribed for people struggling with major depressive disorder, particularly when other treatments haven’t worked. My own journey with mental health has involved trials with different medicines and weighing their impact on daily life. Doctors might pull out tranylcypromine when fatigue, hopelessness, or lack of motivation stick around despite other efforts.
This medicine falls under a class called monoamine oxidase inhibitors, or MAOIs. People might recall stories about doctors recommending new ways of eating or avoiding certain foods with the prescription. The reason has roots in how tranylcypromine works by influencing chemicals in the brain, such as serotonin, norepinephrine, and dopamine. Lower levels of these chemicals often play a part in persistent sadness or an inability to feel pleasure. By stopping the breakdown of these chemicals, tranylcypromine helps some people finally get relief from symptoms that have followed them for years.
Starting tranylcypromine can feel like entering unfamiliar territory. Headaches, dizziness, or changes in blood pressure sometimes show up. Anyone with experience juggling medications for mental health knows the tradeoff between feeling a bit off and feeling completely stuck. Rarely, this drug can trigger a spike in blood pressure if mixed with certain foods or other medicines. Doctors rely on strong communication, sharing detailed instructions about what to avoid, like cheese or cured meats which contain tyramine. The reason stems from the medicine’s impact on enzymes that break down this compound, raising risks if combined.
Reports suggest that for some, tranylcypromine works quickly, bringing a lift in mood or energy after a couple of weeks. That rapid response offers hope, especially for people who have tried selective serotonin reuptake inhibitors (SSRIs) or therapy without much change. But family members, friends, and doctors keep a close eye on side effects. Stories circulate online about people experiencing insomnia, or their blood pressure shooting up during a stressful moment. These stories highlight the importance of regular doctor visits and honest conversations about any changes in mood or physical health.
Living with treatment-resistant depression demands patience and perseverance. Tranylcypromine represents an important option that often saves people from desperation. According to data from the National Institute of Mental Health, nearly seven percent of American adults live with depression each year, and a portion don’t improve with first-line therapies. The ability of tranylcypromine to offer a second or third chance can’t be understated.
Still, long-term recovery doesn’t rest on medication alone. Adding therapy, building steady routines, finding support groups, and working closely with healthcare providers anchors lasting change. Honest discussion about side effects or challenges can help paint a more complete picture. Many people benefit from knowing about dietary restrictions and drug interactions up front, making the medicine less daunting and risks easier to manage.
Modern advances in psychiatry continue to explore ways to ease depression without heavy-handed side effects. For now, tranylcypromine holds value for folks who feel stuck after exhausting other paths. It’s one more tool for dedicated doctors working to match the right care to each individual. For anyone considering it, staying informed and keeping communication open can make the journey a little smoother.
Doctors reach for tranylcypromine sulfate when depression does not budge after more common antidepressants. It has a long track record, showing up in mental health care since the late 1950s. The nature of monoamine oxidase inhibitors (MAOIs) brings promises, but also real risks and challenges people need to know about before starting treatment. I’ve seen cases where someone finally finds relief after years of frustration, but the road often gets rocky with physical and emotional changes along the way.
In my experience, most people report feeling jittery or restless in the days after starting tranylcypromine. Sleep troubles show up quickly: some toss and turn all night, others struggle with vivid, disturbing dreams. Headaches come up a lot, as do dry mouth and dizziness, especially when getting out of bed fast. These symptoms usually seem minor but wear on you if you’re already down.
Weight loss and appetite changes aren’t uncommon. Some folks find their stomach rebels, leading to nausea and occasional vomiting. My own run-in with an MAOI from another class left me wary around pickled foods. Tranylcypromine pushes you to rethink not just medicine, but also what lands on your plate.
Few drugs demand the kind of dietary discipline that tranylcypromine does. Mixing it with foods rich in tyramine—think aged cheese, cured meat, soy sauce—raises blood pressure to dangerously high levels. In extreme situations, people can land in the hospital with headaches pounding behind the eyes, tight chests, and confusion. I’ve heard from patients who said the constant food label checks and restaurant double-checks made everyday life feel stressful, piling on unwanted pressure while trying to heal.
Another heavy concern comes from the drug’s impact on blood pressure. People notice feeling faint or lightheaded, especially after standing up quickly, which scares anyone who already worries about falls or accidents. In my time working with older adults, this came up all the time, because a simple dizzy spell could mean a trip to the ER.
Some people feel suddenly energetic, even agitated. Rarely, tranylcypromine unlocks a racing mind or triggers mania in people who never expected it. I remember one young man who described it as “my foot on the gas and no brakes.” Families worry, too. Sleep disturbances and these new, unpredictable moods shake up homes, especially where depression already caused years of tension.
Suicidal thoughts need open, honest conversations between prescriber and patient. Drugs in this category can spark such thoughts, even as they promise to pull you out of a deep hole. In the clinic, we always circle back to assess for safety, keeping doors and phone lines open in case someone needs an emergency check-in.
Open, ongoing dialogue between the prescriber and the one taking tranylcypromine makes a real difference. Collaboration with a dietitian familiar with MAOIs can help map out a food plan. Nurses double-check blood pressure, and pharmacists screen for dangerous drug interactions—not just prescription meds, but herbs or supplements too. Each of these professionals helps head off trouble before it starts.
Taking tranylcypromine demands planning and support. Most folks do better with a crisis plan and someone close to check in during the rough days. Nobody should have to face these risks alone. With teamwork and honesty, the scary stuff loses some of its power, and people can focus again on fighting depression instead of just fighting their medicine.
Doctors often reach for tranylcypromine sulfate when nothing else brings relief for stubborn depression. This medication lives in a group called MAOIs. I’ve talked to people who run out of patience after trying the usual antidepressants. For folks tired of feeling like a guinea pig, tranylcypromine sometimes stands out, but it’s not one to take lightly. Getting the amount just right can mean the difference between slowly climbing up or knocking things out of balance.
Adults usually start with a small dose—10 mg twice daily seems to pop up in medical guidelines and drug leaflets. Many adjust slowly, only after a week or two, depending on how their bodies and moods react. Most doctors won’t push past 60 mg per day, not because higher amounts suddenly cure more deeply, but because the risks multiply. With tranylcypromine, it’s easier than most realize for blood pressure to spike, headaches to hit, or sleep to go out the window. I’ve heard stories from patients whose mood improved but felt jittery or had trouble sleeping, which signals too much or too fast.
Getting good care isn’t just about prescriptions. Tranylcypromine changes how the body deals with certain foods and medicines. Some supermarket cheeses and common cold remedies can set off serious spikes in blood pressure. A physical reaction like that puts a patient in the emergency room—nobody wants that. Honest conversations with a prescriber help flag those dangers early. If family or friends don’t always understand dietary restrictions, nurses and pharmacists can help everyone get on the same page. You can’t go it alone with a drug like this and hope for the best.
I’ve watched experienced psychiatrists check blood pressure after dose changes. Some clinics ask patients to keep a simple log at home—recording headaches, jitters, heart rates, or any odd feelings. This tracking isn’t busywork. Feelings of chest pain, severe headache, or a racing heart can point to trouble faster than lab tests. For those new to tranylcypromine, early weeks matter most since most issues show up not long after starting or bumping up the dose. Regular appointments give a safety net, with someone paying attention in case a problem slips in.
Sticking to the plan isn’t always easy. Some days call for patience and a little trust. I’ve known people who got frustrated, thinking nothing was happening. Sometimes progress means not getting worse, keeping hope alive until things click into place. Support helps—family, peer support, knowledgeable doctors. Skipping doses or doubling up never makes things go faster. Everyone deserves honest information, and the facts here are clear: steady, careful dosing gives tranylcypromine a real chance to help, without risking a trip to the ER.
Tranylcypromine Sulfate works as an MAOI antidepressant, but the way it interacts with everyday foods can turn dinner into danger. Every psychiatrist has horror stories from the days before labeling got strict. I spent afternoons with folks asking if cheese pizza would land them in the ER. Turns out, the fear isn’t fake.
This drug blocks an enzyme called monoamine oxidase. With that, your body struggles to break down tyramine, a chemical in aged and cured foods. Tyramine sneaks in through tangy blue cheese, sharp cheddar, smoked meats, overripe bananas, soy products, and certain alcoholic drinks like tap beer and red wine. Too much of it, and blood pressure can spike to dangerous levels, sometimes beyond what a hospital can fix in time. These situations land in medical journals and remind families to take a medication list seriously.
Pharmacies often toss cold tablets into a bag without much fuss, but mixing Tranylcypromine with anything containing pseudoephedrine, phenylephrine, or even some cough syrups can trigger a hypertensive crisis. Walking through the cold and flu aisle, it almost feels like every box preys on those not reading tiny labels. I’ve sat through more than one phone call with someone panicking about headache and chest pressure, not realizing that something as common as DayQuil packs a punch when paired with this antidepressant.
Even OTC painkillers have their traps. Meperidine, used for pain and even sometimes shivering, must be avoided. The risk of serotonin syndrome climbs with drugs like tramadol, SSRIs, and some migraine meds (triptans). Emergency rooms sometimes see serotonin syndrome looking like a seizure or stroke, and nurses know to start the questions about antidepressants right away.
No one enjoys repeating food lists or pushing paper with MAOI warnings, but skipping that step makes ambulances busier. Most cooks or caretakers haven’t memorized which soy sauces or cured sausages are safe. Reading labels and asking pharmacy questions every time a new food or pill comes through the door, even after months on the same antidepressant, works better than crossing fingers.
Several studies back up these warnings. Research in “The Journal of Clinical Psychiatry” tracked dozens of hospital admissions tied to blood pressure spikes from food-drug interactions. These were not rare, abstract events — they happen every year. Guidelines from the American Psychiatric Association mention that MAOI diets still matter, even though new drugs with fewer interactions have come along.
Anyone starting Tranylcypromine Sulfate should keep a wallet card listing taboo foods and over-the-counter meds. Bring it to every doctor or pharmacy visit, even if it feels awkward. Save the hotline number for poison control, just in case confusion hits late at night. Find a regular grocery store and stick with brands where ingredients remain predictable. Share the no-cured-meats, no-aged-cheese rule with family and friends, so meals at someone else’s house don’t come with a side of anxiety.
Staying curious and a bit suspicious about food or pill labels keeps surprises out of the bloodstream. Trust between patients, caregivers, and prescribers can keep small mistakes from turning into emergencies. I’ve seen relief grow once people learn the handful of things to dodge — it’s less about living in fear and more about owning each choice. That makes life on this medication safer and more predictable, so the focus can land on mental health instead of the next scary side effect.
Missing a dose of Tranylcypromine Sulfate isn’t the same thing as forgetting your daily vitamins. This medication works as an MAOI, which means it has the job of balancing chemicals in the brain that affect mood. Anybody prescribed Tranylcypromine knows that skipping even one dose can cloud emotions and throw off stability. I recall helping a relative through a rocky stretch when he missed a dose, and the difference in his mood was obvious within a day—extra anxiety, more shifts in energy. Most drugs in this class need steady levels in the blood to do their job, so it makes sense that missing just once can bring trouble.
If you realize you’ve skipped a dose, take it as soon as you remember, unless it’s nearly time for the next one. Doubling up in a short time opens the door for side effects. Think headaches, increased blood pressure, or heart palpitations—some things nobody wants to deal with as a tradeoff. Guidance from pharmacists and healthcare providers always leans toward playing it safe. If you’re uncertain, check in with your prescribing doctor. They know your medical history best.
Overdosing on Tranylcypromine carries more risks than skipping a dose. Signs of overdose often show up fast and hard: severe pounding in the chest, splitting headaches, twitching muscles, confusion, or even seizures. Stories surface from emergency rooms about folks coming in after a mix-up or a mistaken double dose—sometimes scared, sometimes unaware. Tranylcypromine has a narrow margin for safety, so an overdose can’t get brushed aside.
The first thing to do is get medical help right away. Call emergency services or poison control. Trying to wait it out at home or searching for home remedies online only increases danger. Hospitals know how to manage serious reactions and can keep things from getting worse. I’ve seen friends regret waiting too long to get medical care; early help can make the difference between a scare and lasting harm.
Keeping medications in a pill organizer or setting an alarm can cut down on mistakes. I picked up this habit after once forgetting a morning dose and feeling the effects by afternoon. Doctors sometimes tell patients to write down each dose, building a simple log to spot any gaps. Regular check-ins with healthcare teams also help, since doses do get adjusted sometimes.
Many people hesitate to mention missed or extra doses, worried about getting a lecture. Good care depends on honesty—your care team needs to know about any missteps to keep you safe. Pharmacists and doctors appreciate information, not perfection.
Tranylcypromine works differently than most antidepressants. It reacts with foods like aged cheese, cured meats, or soy sauce, sometimes causing dangerous blood pressure spikes. Missing a dose may not erase that risk, but overdosing can heighten it—so no shortcuts on caution.
Also, steer clear of self-medicating. Don’t double up out of fear or skip the next dose because you feel guilty. These reactions often cloud judgment more than solve the problem.
I’ve learned from experience that consistency is everything. Treat every day with this medication like it matters. Get into a routine. Let your doctor know if things get confusing or your routine changes. Keeping that open line can be the difference between stability and struggle.
| Names | |
| Preferred IUPAC name | 2-phenylcyclopropan-1-amine sulfate |
| Other names |
Parnate Tranylcypromine Tranylcypromine hemisulfate 2-Phenylcyclopropylamine sulfate |
| Pronunciation | /ˌtræn.ɪlˈsaɪ.prəˌmiːn ˈsʌl.feɪt/ |
| Identifiers | |
| CAS Number | 13492-01-8 |
| Beilstein Reference | 2328003 |
| ChEBI | CHEBI:9646 |
| ChEMBL | CHEMBL1477 |
| ChemSpider | 8092796 |
| DrugBank | DB00752 |
| ECHA InfoCard | 100.224.213 |
| EC Number | 1.4.3.4 |
| Gmelin Reference | 64177 |
| KEGG | C07481 |
| MeSH | D011932 |
| PubChem CID | 656583 |
| RTECS number | XN8225000 |
| UNII | Q3JTX2U12N |
| UN number | UN2811 |
| CompTox Dashboard (EPA) | DTXSID2020704 |
| Properties | |
| Chemical formula | (C9H11N)2•H2SO4 |
| Molar mass | 275.36 g/mol |
| Appearance | White to almost white crystalline powder |
| Odor | Odorless |
| Density | 0.978 g/cm3 |
| Solubility in water | Soluble in water |
| log P | -0.1 |
| Acidity (pKa) | 8.7 |
| Basicity (pKb) | 5.65 |
| Magnetic susceptibility (χ) | -82.5×10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.662 |
| Viscosity | Viscous liquid |
| Dipole moment | 3.75 D |
| Pharmacology | |
| ATC code | N06AF04 |
| Hazards | |
| Main hazards | May cause respiratory irritation; may cause damage to organs through prolonged or repeated exposure; harmful if swallowed |
| GHS labelling | GHS05, GHS07 |
| Pictograms | `GHS06,GHS08` |
| Signal word | Danger |
| Hazard statements | H302: Harmful if swallowed. |
| Precautionary statements | P201, P202, P264, P270, P301+P312, P330, P405, P501 |
| NFPA 704 (fire diamond) | 1-2-0 Health:1 Flammability:2 Instability:0 Special: |
| Flash point | 135 °C |
| Lethal dose or concentration | LD50 (rat, oral): 6.4 mg/kg |
| LD50 (median dose) | Tranylcypromine sulfate LD50 (oral, rat): 7 mg/kg |
| NIOSH | NIOSH: SY8575000 |
| PEL (Permissible) | Not established |
| REL (Recommended) | 1.5-3 mg/kg |
| IDLH (Immediate danger) | Not Established |
| Related compounds | |
| Related compounds |
Phenelzine Isocarboxazid Selegiline Rasagiline Pargyline |
